North Bergen, NJ-based Vitamin Shoppe, Inc. announced the public offering of 9,096,077 shares of its common stock has priced at $17 per share. The shares will begin trading on the New York Stock Exchange under the ticker symbol “VSI.”

Vitamin Shoppe is offering 7,666,667 shares of common stock and selling stockholders are offering the remaining 1,429,410 shares in the offering. The underwriters have a 30-day option to purchase up to an additional 1,364,411 shares from the selling stockholders.

Vitamin Shoppe intends to use the net proceeds of approximately $121 million from the offering for the pro rata redemption of approximately $72.5 million of its outstanding preferred stock, the repurchase of approximately $45 million in aggregate principal amount of its outstanding senior secured notes, and the payment of offering-related expenses.

J.P.Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint book-running managers for the offering. Piper Jaffray, Robert W. Baird & Co. and Stifel Nicolaus are the co-managers of the offering.